Navigation Links
MediSapiens Launches OncoGenomics Explorer, First-in-Kind Cloud Computing Application for Personalized Genomics
Date:9/17/2012

HELSINKI, Finland and SAN FRANCISCO, September 17, 2012 /PRNewswire/ --

MediSapiens launches first-in-kind fully integrated and unified cloud computing application that harnesses the power of Big Data and enables knowledge-based drug discovery and repositioning for personalized genomics.

This application, called OncoGenomics Explorer, is the next stage of bioinformatics applications for drug discovery. Unlike other cloud computing genomics applications, the Oncogenomics Explorer allows flexible mining of all public and private multi-dimensional biological data available and provides the user with an intuitive and concise visualization and analysis of this vast pool of information. As the first application of its kind, OncoGenomics Explorer also features a revolutionary new search algorithm that allows researchers to perform complex genomics data searches using plain text search phrases. As the result of strict data unification process, OncoGenomics Explorer users will always get straightforward and reliable results to their queries.

The new software was launched today at the Bio-IT World's Cloud Summit in San Francisco by the company's VP of Business Development, Mr. Rami Kakonen.

OncoGenomics Explorer seamlessly integrates multi-dimensional genomics (mutation, methylation, CNV, mRNA) data from a single sample to create a comprehensive genomics tool for scientist fighting to find the cure to cancer.

OncoGenomics Explorer is an ideal tool for the entire pharmaceutical industry. It will significantly lower the drug discovery costs by allowing more accurate target validation and data consolidation. It is also the first web-based omics tool to truly enable personalized genomics because OncoGenomics Explorer allows pharmaceutical scientists to stratify and recruit patients for clinical trials based on their personal genetic signature. This way new therapeutic agents are more often administered to patients who are likely to benefit from them. This, in turn, decreases drug development attrition and overall costs, decreases the number of patients needlessly suffering from the adverse effects of INDs, and ultimately significantly improves our odds in winning the fight against cancer.

Medisapiens launched its first cloud computing application, the IST Online, in the forefront of web-based gene expression data applications as early as 2005. This system has been widely used in both academic and pharmaceutical drug discovery. The new OncoGenomics Explorer sets a new standard for fully integrated Big Data cloud computing.

For additional information about MediSapiens, or OncoGenomics Explorer, please contact Tommi Pisto, CEO, MediSapiens (tommi.pisto@medisapiens.com), +358-50-363-1848.



'/>"/>
SOURCE MediSapiens Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
3. Mylan Launches Generic Version of Zyprexa® Tablets
4. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
5. American Academy of Family Physicians Foundation Launches Cities for Life
6. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
7. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
8. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
9. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
10. Practice Fusion Launches API to Democratize Lab Integrations
11. Kmart® Launches New Pet Prescription Program And Purina® Treat Giveaway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):